Germany has a high demand in meniscal allograft transplantation but is subject to health economic and legal challenges: a survey of the German Knee Society - Report - MDSpire
Advertisement
Germany has a high demand in meniscal allograft transplantation but is subject to health economic and legal challenges: a survey of the German Knee Society
High Demand for Meniscal Allograft Transplantation in Germany Faces Economic and Legal Hurdles
Overview
A survey among German Knee Society members revealed a high clinical demand for meniscal allograft transplantation (MAT) in Germany despite limited availability. Key barriers include reimbursement issues, legal restrictions on donor graft use, and graft availability, which hinder timely MAT implementation.
Background
Meniscal preservation is critical to prevent early osteoarthritis, yet many meniscal tears remain irreparable, necessitating meniscal resection. Patients with meniscus deficiency often suffer from pain and reduced function, for which MAT is a viable treatment to improve symptoms and quality of life. However, in Germany, legal and economic challenges restrict access to meniscal allografts, prompting investigation into the current status and demand for MAT.
91.5% of respondents agree MAT is clinically necessary in Germany.
More than half of participants perform over 100 meniscal surgeries annually.
Only 35.5% have performed MAT, with most performing fewer than 5 procedures.
Fresh-frozen grafts are the most commonly used meniscal allografts.
Reimbursement issues, legal restrictions on donor graft use, and graft availability are the primary barriers to MAT.
When MAT is not feasible, alternatives include lower limb realignment, physical therapy, unicompartmental knee arthroplasty, and artificial meniscal implants.
Clinical Implications
Clinicians should recognize the high demand for MAT in Germany and advocate for improved access to meniscal allografts. Awareness of legal and reimbursement barriers is essential to navigate treatment options effectively. Alternative treatments should be considered when MAT is not available, but efforts to overcome systemic hurdles are critical to optimize patient outcomes.
Conclusion
Despite strong clinical demand for meniscal allograft transplantation in Germany, economic and legal challenges significantly limit its availability and use. Addressing these barriers is necessary to integrate MAT more fully into routine knee preservation strategies.
References
German Knee Society Survey 2021 -- High Demand for Meniscal Allograft Transplantation in Germany
by Philipp W. Winkler, Svea Faber, Maurice Balke, Sebastian Metzlaff, Thomas R. Niethammer, Philip P. Roessler, Ralf Henkelmann, Alexander Kurme, Sebastian Colcuc, Gerald Zimmermann, Wolf Petersen, Theresa A. Diermeier